アイルランドにおけるがん臨床試験における持続可能性へのステップストーン
Angela Clayton-Lea1, Calvin R Flynn2, Claire Hopkins1
1Cancer Trials Ireland, RCSI House, D02 H903 Dublin, Ireland.
Current oncology (Toronto, Ont.)
|August 27, 2025
まとめ
癌の臨床試験は 温室効果ガスの排出量にも大きな影響を及ぼします この研究では,持続可能性に対する意識は低いが,アイルランドにおけるがん研究専門家の参加意欲は高いことが明らかになり,よりグリーンな実践のための主要な障壁と促進要因を特定した.
科学分野:
- 環境科学
- 公衆衛生
- 腫瘍学
背景:
- 保健医療は温室効果ガスの排出に寄与し 持続可能な実践が求められます
- 癌の臨床試験は医療における排出量の重要な構成要素です.
- 気候変動の危機は 研究における持続可能性に 緊急の注意を払うことを求めています
研究 の 目的:
- アイルランドのがん臨床試験コミュニティにおける持続可能性の意識,態度,実践を評価する.
- 癌研究における緑のイニシアチブを実施する際の障害と有効要因を特定する.
- ターゲットに掲げられた持続可能性への介入の基礎となる.
主な方法:
- アイルランドの613人の癌研究専門家に横断調査が配布されました.
- この調査は,持続可能性ツール,認識された排出源,トレーニング,信頼,障壁/有効要因の認識を評価した.
- 回答率は20. 6%で,127人の参加者からデータを得ました.
主要な成果:
- 既存のサステナビリティツール (例えば,サステナビリティ・クリニック・トライアル・グループのガイドライン,NIHR計算器) の認識が低い.
- 訓練と信頼が限られているにもかかわらず,持続可能性のイニシアチブに参加する意欲が高い (86%).
- 主な排出要因は試験旅行,サンプルキット廃棄物,試験セットアップです.
結論:
- アイルランドのがん臨床試験部門では,持続可能性に関する意識と訓練に重大な欠陥がある.
- 教育の欠如や 制度的な支援の欠如といった障壁を 克服することが重要です
- 癌治験のプロセス,設計,資金調達に 持続可能性を統合するために 調整された介入が必要である.
関連する概念動画
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Nursing Ethical Principles II
1.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.3K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K


